Pulse Biosciences (PLSE) News Today $17.61 -0.03 (-0.17%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Barclays PLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE)Barclays PLC lifted its position in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE - Free Report) by 361.4% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 30,306 shares of the company's stock after purJanuary 18 at 3:11 AM | marketbeat.comPulse Biosciences announces Paul LaViolette as CEOJanuary 10, 2025 | markets.businessinsider.comPulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive OfficerJanuary 10, 2025 | gurufocus.comPulse Biosciences Appoints Co-Chairman Paul LaViolette As CEOJanuary 10, 2025 | markets.businessinsider.comPulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive OfficerJanuary 10, 2025 | finance.yahoo.comPulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 3, 2025 | finance.yahoo.comPulse Biosciences (NASDAQ:PLSE) Trading 6.1% Higher - Should You Buy?Pulse Biosciences (NASDAQ:PLSE) Shares Up 6.1% - Here's What HappenedJanuary 3, 2025 | marketbeat.comGeode Capital Management LLC Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE)Geode Capital Management LLC boosted its position in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE - Free Report) by 7.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 457,165 shares of the company's stock after purchasiJanuary 3, 2025 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Rating Increased to Sell at StockNews.comStockNews.com raised Pulse Biosciences to a "sell" rating in a report on Thursday.January 2, 2025 | marketbeat.comState Street Corp Buys 69,696 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE)State Street Corp grew its holdings in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE - Free Report) by 17.8% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 461,333 shares of the company's stock after purchasing an additioDecember 28, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Trading Down 2.2% - Time to Sell?Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 2.2% - Time to Sell?December 26, 2024 | marketbeat.comPulse Biosciences: Constructive On Nano-Pulse AssetsDecember 25, 2024 | seekingalpha.comPulse Biosciences (NASDAQ:PLSE) Shares Gap Up - Should You Buy?Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up - Still a Buy?December 24, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Stock Rating Upgraded by StockNews.comStockNews.com upgraded Pulse Biosciences to a "sell" rating in a report on Tuesday.December 24, 2024 | marketbeat.comPulse Biosciences, Inc. Announces Planned Redemption of WarrantsDecember 23, 2024 | businesswire.comPulse Biosciences, Inc. (NASDAQ:PLSE) CEO Sells $871,000.00 in StockDecember 21, 2024 | insidertrades.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New $588,000 Investment in Pulse Biosciences, Inc. (NASDAQ:PLSE)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in Pulse Biosciences, Inc. (NASDAQ:PLSE - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 33,535 shares of the compaDecember 21, 2024 | marketbeat.comPulse Biosciences Inc.December 20, 2024 | wsj.comInsider Selling: Pulse Biosciences, Inc. (NASDAQ:PLSE) CEO Sells 50,000 Shares of StockPulse Biosciences, Inc. (NASDAQ:PLSE - Get Free Report) CEO Burke Thomas Barrett sold 50,000 shares of the stock in a transaction that occurred on Wednesday, December 11th. The stock was sold at an average price of $17.42, for a total value of $871,000.00. Following the completion of the transaction, the chief executive officer now owns 63,172 shares in the company, valued at approximately $1,100,456.24. The trade was a 44.18 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.December 20, 2024 | marketbeat.comPulse Biosciences, Inc. Announces Election to Exercise Company WarrantsDecember 19, 2024 | businesswire.comPulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular SurgeryDecember 18, 2024 | finance.yahoo.comInsider Buying: Pulse Biosciences, Inc. (NASDAQ:PLSE) Director Purchases 55,256 Shares of StockDecember 18, 2024 | insidertrades.comPulse Biosciences, Inc. (NASDAQ:PLSE) Director Buys $949,298.08 in StockPulse Biosciences, Inc. (NASDAQ:PLSE - Get Free Report) Director Robert W. Duggan acquired 55,256 shares of the stock in a transaction dated Friday, December 13th. The stock was acquired at an average cost of $17.18 per share, with a total value of $949,298.08. Following the completion of the transaction, the director now owns 42,328,717 shares in the company, valued at approximately $727,207,358.06. This represents a 0.13 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is accessible through this link.December 17, 2024 | marketbeat.comPulse announces publication of nano-PFA Cardiac Surgical System dataDecember 17, 2024 | markets.businessinsider.comPulse Biosciences (NASDAQ:PLSE) Trading Up 5.3% - Here's What HappenedPulse Biosciences (NASDAQ:PLSE) Trading 5.3% Higher - Here's WhyDecember 17, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Shares Gap Up Following Insider Buying ActivityPulse Biosciences (NASDAQ:PLSE) Shares Gap Up Following Insider Buying ActivityDecember 16, 2024 | marketbeat.comRobert Duggan Spends US$972k On Pulse Biosciences StockDecember 16, 2024 | finance.yahoo.comCharles Schwab Investment Management Inc. Has $2.60 Million Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE)Charles Schwab Investment Management Inc. boosted its position in shares of Pulse Biosciences, Inc. (NASDAQ:PLSE - Free Report) by 193.0% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 148,114 shares of the company's stock after purchasingDecember 16, 2024 | marketbeat.comInsider Buying: Pulse Biosciences, Inc. (NASDAQ:PLSE) Director Buys 56,054 Shares of StockDecember 14, 2024 | insidertrades.comInsider Buying: Pulse Biosciences, Inc. (NASDAQ:PLSE) Director Purchases 56,054 Shares of StockPulse Biosciences, Inc. (NASDAQ:PLSE - Get Free Report) Director Robert W. Duggan acquired 56,054 shares of the company's stock in a transaction dated Wednesday, December 11th. The shares were purchased at an average cost of $17.35 per share, for a total transaction of $972,536.90. Following the purchase, the director now directly owns 42,228,057 shares in the company, valued at approximately $732,656,788.95. This trade represents a 0.13 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.December 13, 2024 | marketbeat.comTop Key Executive Robert Duggan, Pulse Biosciences, Inc.'s (NASDAQ:PLSE) largest shareholder sees value of holdings go down 13% after recent dropDecember 12, 2024 | uk.finance.yahoo.comPulse Biosciences CEO Resigns Amid Leadership TransitionDecember 6, 2024 | tipranks.comPulse Biosciences (NASDAQ:PLSE) Trading 7.4% Higher - What's Next?Pulse Biosciences (NASDAQ:PLSE) Trading Up 7.4% - Should You Buy?December 6, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Trading Up 9.3% - Should You Buy?Pulse Biosciences (NASDAQ:PLSE) Trading 9.3% Higher - Should You Buy?November 22, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Is In A Good Position To Deliver On Growth PlansNovember 16, 2024 | uk.finance.yahoo.comPLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024November 15, 2024 | investorplace.comPulse Biosciences Inc PLSENovember 13, 2024 | morningstar.comPLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024November 12, 2024 | investorplace.comPLSE Stock Earnings: Pulse Biosciences Reported Results for Q2 2024November 11, 2024 | investorplace.comPulse Biosciences (NASDAQ:PLSE) Trading 7.6% Higher - Still a Buy?Pulse Biosciences (NASDAQ:PLSE) Trading Up 7.6% - Time to Buy?November 5, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Stock Quotes, Forecast and News SummaryNovember 1, 2024 | benzinga.comPulse Biosciences Reports Q3 2024 Financials and DevelopmentsNovember 1, 2024 | markets.businessinsider.comPulse Biosciences Inc (6L8.MU)October 31, 2024 | ca.finance.yahoo.comPulse Biosciences Reports Positive Data From Benign Thyroid StudyOctober 31, 2024 | marketwatch.comPulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid AssociationOctober 31, 2024 | businesswire.comPulse Biosciences (NASDAQ:PLSE) Announces Earnings ResultsPulse Biosciences (NASDAQ:PLSE - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.21) earnings per share for the quarter. During the same period in the previous year, the firm posted ($0.19) EPS.October 31, 2024 | marketbeat.comPulse Biosciences, Inc. (PLSE) Q3 2024 Earnings Call TranscriptOctober 31, 2024 | seekingalpha.comPulse Biosciences Inc (PLSE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...October 31, 2024 | finance.yahoo.comPulse Biosciences (NASDAQ:PLSE) Shares Pass Below 50-Day Moving Average - What's Next?Pulse Biosciences (NASDAQ:PLSE) Shares Pass Below 50 Day Moving Average - Should You Sell?October 31, 2024 | marketbeat.comPulse Biosciences Reports Business Updates and Third Quarter 2024 Financial ResultsOctober 30, 2024 | businesswire.com Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address PLSE Media Mentions By Week PLSE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PLSE News Sentiment▼0.840.48▲Average Medical News Sentiment PLSE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PLSE Articles This Week▼13▲PLSE Articles Average Week Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PRCT News Today NVST News Today IRTC News Today NVCR News Today LIVN News Today ENOV News Today WRBY News Today TNDM News Today LMAT News Today CNMD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PLSE) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PLSE Stock Alerts